226 related articles for article (PubMed ID: 2421872)
1. Hydrolytic cleavage of methotrexate gamma-polyglutamates by folylpolyglutamyl hydrolase derived from various tumors and normal tissues of the mouse.
Samuels LL; Goutas LJ; Priest DG; Piper JR; Sirotnak FM
Cancer Res; 1986 May; 46(5):2230-5. PubMed ID: 2421872
[TBL] [Abstract][Full Text] [Related]
2. Differing specificities for 4-aminofolate analogues of folylpolyglutamyl synthetase from tumors and proliferative intestinal epithelium of the mouse with significance for selective antitumor action.
Rumberger BG; Barrueco JR; Sirotnak FM
Cancer Res; 1990 Aug; 50(15):4639-43. PubMed ID: 2369741
[TBL] [Abstract][Full Text] [Related]
3. Differential synthesis of methotrexate polyglutamates in normal proliferative and neoplastic mouse tissues in vivo.
Poser RG; Sirotnak FM; Chello PL
Cancer Res; 1981 Nov; 41(11 Pt 1):4441-6. PubMed ID: 6171339
[TBL] [Abstract][Full Text] [Related]
4. Studies on the in vivo synthesis of methotrexate polyglutamates and their efflux properties in normal, proliferative, and neoplastic mouse tissues.
Poser RG; Sirotnak FM
Adv Exp Med Biol; 1983; 163():259-74. PubMed ID: 6193689
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of methotrexate polyglutamates in L1210 murine leukemia cells.
Whitehead VM
Cancer Res; 1977 Feb; 37(2):408-12. PubMed ID: 832265
[TBL] [Abstract][Full Text] [Related]
6. Proliferation-dependent cytotoxicity of methotrexate in murine L5178Y leukemia.
Fernandes DJ; Sur P; Kute TE; Capizzi RL
Cancer Res; 1988 Oct; 48(20):5638-44. PubMed ID: 2458828
[TBL] [Abstract][Full Text] [Related]
7. Similar differential for total polyglutamylation and cytotoxicity among various folate analogues in human and murine tumor cells in vitro.
Samuels LL; Moccio DM; Sirotnak FM
Cancer Res; 1985 Apr; 45(4):1488-95. PubMed ID: 3978616
[TBL] [Abstract][Full Text] [Related]
8. Secretion of gamma-glutamyl hydrolase in vitro.
O'Connor BM; Rotundo RF; Nimec Z; McGuire JJ; Galivan J
Cancer Res; 1991 Aug; 51(15):3874-81. PubMed ID: 1713122
[TBL] [Abstract][Full Text] [Related]
9. Role of folylpolyglutamate synthetase in the regulation of methotrexate polyglutamate formation in H35 hepatoma cells.
Johnson TB; Nair MG; Galivan J
Cancer Res; 1988 May; 48(9):2426-31. PubMed ID: 2451560
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate intracellular disposition in acute lymphoblastic leukemia: a mathematical model of gamma-glutamyl hydrolase activity.
Panetta JC; Wall A; Pui CH; Relling MV; Evans WE
Clin Cancer Res; 2002 Jul; 8(7):2423-9. PubMed ID: 12114448
[TBL] [Abstract][Full Text] [Related]
11. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.
Matherly LH; Barlowe CK; Goldman ID
Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428
[TBL] [Abstract][Full Text] [Related]
12. Formation of methotrexate polyglutamates in purified myeloid precursor cells from normal human bone marrow.
Koizumi S; Curt GA; Fine RL; Griffin JD; Chabner BA
J Clin Invest; 1985 Mar; 75(3):1008-14. PubMed ID: 2579975
[TBL] [Abstract][Full Text] [Related]
13. Metabolic turnover of methotrexate polyglutamates in lysosomes derived from S180 cells. Definition of a two-step process limited by mediated lysosomal permeation of polyglutamates and activating reduced sulfhydryl compounds.
Barrueco JR; O'Leary DF; Sirotnak FM
J Biol Chem; 1992 Aug; 267(22):15356-61. PubMed ID: 1379226
[TBL] [Abstract][Full Text] [Related]
14. [Separation of methotrexate-polyglutamates by capillary electrophoresis and its application to the measurement of gamma-glutamyl hydrolase activity in human leukemia cells in culture].
Takemura Y; Kobayashi H; Sekiguchi S
Rinsho Byori; 1996 Jan; 44(1):51-6. PubMed ID: 8691640
[TBL] [Abstract][Full Text] [Related]
15. gamma-Glutamyl hydrolase and folylpolyglutamate synthetase activities predict polyglutamylation of methotrexate in acute leukemias.
Longo GS; Gorlick R; Tong WP; Lin S; Steinherz P; Bertino JR
Oncol Res; 1997; 9(5):259-63. PubMed ID: 9306433
[TBL] [Abstract][Full Text] [Related]
16. Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductase.
Jolivet J; Chabner BA
J Clin Invest; 1983 Sep; 72(3):773-8. PubMed ID: 6193143
[TBL] [Abstract][Full Text] [Related]
17. Proposed mechanism of therapeutic selectivity for 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia based upon lower capacities for transport and phosphorylation in proliferative intestinal epithelium compared to tumor cells.
Barrueco JR; Jacobsen DM; Chang CH; Brockman RW; Sirotnak FM
Cancer Res; 1987 Feb; 47(3):700-6. PubMed ID: 3802076
[TBL] [Abstract][Full Text] [Related]
18. Role of polyglutamates in methotrexate action.
Wilmanns W; Schalhorn A
Chemioterapia; 1985 Oct; 4(5):349-53. PubMed ID: 2416481
[TBL] [Abstract][Full Text] [Related]
19. Enhanced polyglutamylation of aminopterin relative to methotrexate in the Ehrlich ascites tumor cell in vitro.
Matherly LH; Voss MK; Anderson LA; Fry DW; Goldman ID
Cancer Res; 1985 Mar; 45(3):1073-8. PubMed ID: 2578870
[TBL] [Abstract][Full Text] [Related]
20. Characterization of human cellular gamma-glutamyl hydrolase.
Rhee MS; Lindau-Shepard B; Chave KJ; Galivan J; Ryan TJ
Mol Pharmacol; 1998 Jun; 53(6):1040-6. PubMed ID: 9614206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
